{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:06:11Z","timestamp":1792001171541,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011614","name":"University of Kelaniya","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011614","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01401-5","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:33:08Z","timestamp":1771061588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and Epidemiologic Characteristics of Patients with Hepatocellular Carcinoma in South Asia: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Madunil Anuk","family":"Niriella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyumi Madushika","family":"Dayananda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viranga Sathsarani","family":"Ranathunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indeewari Prathibha","family":"Wijesingha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiloka","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hithanadura Janaka","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"3","key":"1401_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1401_CR2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021.","journal-title":"J Hepatol"},{"issue":"2","key":"1401_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"AG Singal","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol. 2020;72(2):250\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.025.","journal-title":"J Hepatol"},{"key":"1401_CR4","unstructured":"Ferlay J, Laversanne M, Ervik M et al. Estimated number of new cases of Liver and intrahepatic bile duct cancers from 2022 to 2045, Incidence, Both sexes, age [0\u201385+]. Global Cancer Observatory: Cancer Tomorrow (version 1.1). Lyon, France: International Agency for Research on Cancer. Published 2024. Accessed March 25, 2024. https:\/\/gco.iarc.fr\/tomorrow\/en\/dataviz\/tables?cancers=11&single_unit=50000&types=0&multiple_populations=1"},{"issue":"2","key":"1401_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017.","journal-title":"J Hepatol"},{"issue":"S1","key":"1401_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(S1):4\u201313. https:\/\/doi.org\/10.1002\/hep.31288.","journal-title":"Hepatology"},{"issue":"4","key":"1401_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","volume":"23","author":"DJH Tan","year":"2022","unstructured":"Tan DJH, Ng CH, Lin SY, et al. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. Lancet Oncol. 2022;23(4):521\u201330. https:\/\/doi.org\/10.1016\/S1470-2045(22)00078-X.","journal-title":"Lancet Oncol"},{"key":"1401_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100220","volume":"15","author":"MA Niriella","year":"2023","unstructured":"Niriella MA, Ediriweera DS, Withanage MY, Darshika S, De Silva ST, de Janaka Silva H. Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian region: a meta-analysis. The Lancet Regional Health - Southeast Asia. 2023;15:100220. https:\/\/doi.org\/10.1016\/j.lansea.2023.100220.","journal-title":"The Lancet Regional Health - Southeast Asia"},{"issue":"4","key":"1401_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317\u201370. https:\/\/doi.org\/10.1007\/s12072-017-9799-9. Epub 2017 Jun 15. PMID: 28620797; PMCID: PMC5491694.","journal-title":"Hepatol Int"},{"key":"1401_CR10","doi-asserted-by":"publisher","unstructured":"Chapter 5. Systematic reviews of prevalence and incidence. JBI manual for evidence synthesis. JBI; 2020. https:\/\/doi.org\/10.46658\/JBIMES-20-06.","DOI":"10.46658\/JBIMES-20-06"},{"issue":"11","key":"1401_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974\u20138. https:\/\/doi.org\/10.1136\/jech-2013-203104.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"1401_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4780060104","volume":"6","author":"RJ Simes","year":"1987","unstructured":"Simes RJ. Confronting publication bias: a cohort design for meta-analysis. Stat Med. 1987;6(1):11\u201329. https:\/\/doi.org\/10.1002\/sim.4780060104.","journal-title":"Stat Med"},{"issue":"6","key":"1401_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/qjmed\/hcn033","volume":"101","author":"R Kumar","year":"2008","unstructured":"Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM Int J Med. 2008;101(6):479\u201385. https:\/\/doi.org\/10.1093\/qjmed\/hcn033.","journal-title":"QJM Int J Med"},{"issue":"3\u20134","key":"1401_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000231886","volume":"77","author":"SB Paul","year":"2009","unstructured":"Paul SB, Chalamalasetty SB, Vishnubhatla S, et al. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology. 2009;77(3\u20134):162\u201371. https:\/\/doi.org\/10.1159\/000231886.","journal-title":"Oncology"},{"issue":"2","key":"1401_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12664-021-01209-0","volume":"41","author":"B Musunuri","year":"2022","unstructured":"Musunuri B, Shetty S, Bhat G, Udupa K, Pai A. Profile of patients with hepatocellular carcinoma: an experience from a tertiary care center in India. Indian J Gastroenterol. 2022;41(2):127\u201334. https:\/\/doi.org\/10.1007\/s12664-021-01209-0.","journal-title":"Indian J Gastroenterol"},{"issue":"1","key":"1401_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.18203\/2349-3933.ijam20223397","volume":"10","author":"RS Marimuthu","year":"2022","unstructured":"Marimuthu RS, Bavanandam S, Selvam S. Study on the clinical and etiological profile of hepatocellular carcinoma in a tertiary care centre in South India: a prospective observational study. Int J Adv Med. 2022;10(1):31. https:\/\/doi.org\/10.18203\/2349-3933.ijam20223397.","journal-title":"Int J Adv Med"},{"issue":"1","key":"1401_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.18203\/issn.2454-2156.intjscirep20150205","volume":"1","author":"S Mukherjee","year":"2015","unstructured":"Mukherjee S, Dhar K, Datta S, Mukherjee AK. Hepatocellular carcinoma in Eastern India, a detail analytical report from a tertiary care hospital. Int J Sci Rep. 2015;1(1):69. https:\/\/doi.org\/10.18203\/issn.2454-2156.intjscirep20150205.","journal-title":"Int J Sci Rep"},{"key":"1401_CR18","doi-asserted-by":"publisher","unstructured":"Prabhakar T, Kaushal K, Prasad M et al. Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis-a multi-centric study. Published online 2022. https:\/\/doi.org\/10.21203\/rs.3.rs-2356539\/v1","DOI":"10.21203\/rs.3.rs-2356539\/v1"},{"issue":"6","key":"1401_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1046\/j.1440-1746.2001.02476.x","volume":"16","author":"SK Sarin","year":"2001","unstructured":"Sarin SK, Thakur V, Guptan RC, et al. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol. 2001;16(6):666\u201373. https:\/\/doi.org\/10.1046\/j.1440-1746.2001.02476.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1401_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12664-022-01314-8","volume":"42","author":"A Koshy","year":"2023","unstructured":"Koshy A, Devadas K, Panackel C, et al. Multi-center prospective survey of hepatocellular carcinoma in Kerala: more than 1,200 cases. Indian J Gastroenterol. 2023;42(2):233\u201340. https:\/\/doi.org\/10.1007\/s12664-022-01314-8.","journal-title":"Indian J Gastroenterol"},{"issue":"6","key":"1401_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jceh.2021.02.002","volume":"11","author":"S Tohra","year":"2021","unstructured":"Tohra S, Duseja A, Taneja S, et al. Experience with changing etiology and nontransplant curative treatment modalities for hepatocellular carcinoma in a real-life setting\u2014a retrospective descriptive analysis. J Clin Exp Hepatol. 2021;11(6):682\u201390. https:\/\/doi.org\/10.1016\/j.jceh.2021.02.002.","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"1401_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12664-013-0373-7","volume":"33","author":"A Sood","year":"2014","unstructured":"Sood A, Midha V, Goyal O, Goyal P, Sood N, Sharma SK. Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in Northern India. Indian J Gastroenterol. 2014;33(1):35\u201340. https:\/\/doi.org\/10.1007\/s12664-013-0373-7.","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"1401_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ijc.27993","volume":"133","author":"M Asim","year":"2013","unstructured":"Asim M, Sarma MP, Kar P. Etiological and molecular profile of hepatocellular cancer from India. Int J Cancer. 2013;133(2):437\u201345. https:\/\/doi.org\/10.1002\/ijc.27993.","journal-title":"Int J Cancer"},{"issue":"1","key":"1401_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.18203\/2320-6012.ijrms20185097","volume":"7","author":"PK Chandrakar","year":"2018","unstructured":"Chandrakar PK, Choudhary V, Azad SK, Beck M. Common causes and trends of hepatocellular carcinoma at regional cancer centre Raipur, India. Int J Res Med Sci. 2018;7(1):85. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20185097.","journal-title":"Int J Res Med Sci"},{"issue":"1","key":"1401_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0049475512473600","volume":"43","author":"S Pal","year":"2013","unstructured":"Pal S, Ramachandran J, Kurien RT, et al. Hepatocellular carcinoma continues to be diagnosed in the advanced stage: profile of hepatocellular carcinoma in a tertiary care hospital in South India. Trop Doct. 2013;43(1):25\u20136. https:\/\/doi.org\/10.1177\/0049475512473600.","journal-title":"Trop Doct"},{"issue":"7","key":"1401_CR26","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1440-1746.2007.04908.x","volume":"22","author":"M Kumar","year":"2007","unstructured":"Kumar M, Kumar R, Hissar SS, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol. 2007;22(7):1104\u201311. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.04908.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"1401_CR27","unstructured":"Nongkynrih A, Jagtap V, Purnima Devi L, et al. Clinical and Epidemiological Profile of Hepatocellular Carcinoma (HCC): Retrospective Analysis from High Incidence Zone in North East India. https:\/\/www.researchgate.net\/publication\/350041118."},{"issue":"92","key":"1401_CR28","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.18410\/jebmh\/2017\/1114","volume":"4","author":"P Narayanan","year":"2017","unstructured":"Narayanan P, Saifudhin Ashraf AA, Philip A. HEPATOCELLULAR CARCINOMA PROFILE IN A TERTIARY CARE CENTRE. J Evid Based Med Healthc. 2017;4(92):5564\u20136. https:\/\/doi.org\/10.18410\/jebmh\/2017\/1114.","journal-title":"J Evid Based Med Healthc"},{"key":"1401_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-6-137","volume":"6","author":"AS Butt","year":"2013","unstructured":"Butt AS, Hamid S, Wadalawala AA, Ghufran M, Javed AA, Farooq O, et al. Hepatocellular carcinoma in native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma. BMC Res Notes. 2013;6:137. https:\/\/doi.org\/10.1186\/1756-0500-6-137.","journal-title":"BMC Res Notes"},{"issue":"2","key":"1401_CR30","first-page":"272","volume":"8","author":"MA Yusuf","year":"2007","unstructured":"Yusuf MA, Badar F, Meerza F, Khokhar RA, Ali FA, Sarwar S, et al. Survival from hepatocellular carcinoma at a cancer hospital in Pakistan. Asian Pac J Cancer Prev. 2007;8(2):272\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"1401_CR31","first-page":"510","volume":"20","author":"A Abbasi","year":"2010","unstructured":"Abbasi A, Butt N, Bhutto AR, Gulzar K, Munir SM. Hepatocellular carcinoma: a clinicopathological study. J Coll Physicians Surg Pak. 2010;20(8):510\u20133.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"7","key":"1401_CR32","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.47391\/JPMA.826","volume":"71","author":"L Alam","year":"2021","unstructured":"Alam L. A year of hepatocellular carcinoma at a glance. Demographics, biochemical and radiological characteristics and treatment modalities from a specialized facility of Pakistan. J Pak Med Assoc. 2021;71(7):1849\u201355. https:\/\/doi.org\/10.47391\/JPMA.826.","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"1401_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1055\/s-0041-1729451","volume":"10","author":"ABH Bhatti","year":"2021","unstructured":"Bhatti ABH, Sheikh AAE, Mahmud US, et al. Clinical profile and treatment of hepatocellular carcinoma: a single-center experience. South Asian J Cancer. 2021;10(2):76\u201380. https:\/\/doi.org\/10.1055\/s-0041-1729451.","journal-title":"South Asian J Cancer"},{"key":"1401_CR34","unstructured":"Shehzad A, Sajjad R, Shabbir K, Qureshi ZA, Saeed F, Qamar A. Hepatocellular carcinoma at initial presentation and its subsequent therapeutic options offered: a tertiary care hospital experience. Pakistan Armed Forces Med J. 2019;69(5):1051\u201356."},{"issue":"4","key":"1401_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/004947550103100419","volume":"31","author":"S Sharieff","year":"2001","unstructured":"Sharieff S, Burney KA, Ahmad N, Salam A, Siddiqui T. Radiological features of hepatocellular carcinoma in Southern Pakistan. Trop Doct. 2001;31(4):224\u20135. https:\/\/doi.org\/10.1177\/004947550103100419.","journal-title":"Trop Doct"},{"issue":"3","key":"1401_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4038\/cmj.v63i3.8724","volume":"63","author":"BKS Bulathsinhala","year":"2018","unstructured":"Bulathsinhala BKS, Siriwardana RC, Gunetilleke MB, Niriella MA, Dassanayake A. Clinical characteristics and outcomes of hepatocellular carcinoma: results from prospective study, from a tertiary referral center in Sri Lanka. Ceylon Med J. 2018;63(3):133. https:\/\/doi.org\/10.4038\/cmj.v63i3.8724.","journal-title":"Ceylon Med J"},{"key":"1401_CR37","doi-asserted-by":"publisher","unstructured":"SiriwardanaC RC, Liyanage AH. MBG. Hepatocellular Carcinoma in Sri Lanka.; 2013. https:\/\/doi.org\/10.4038\/sljs.v31i2.5956","DOI":"10.4038\/sljs.v31i2.5956"},{"key":"1401_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232121","author":"M Al-Amin Shawon","year":"2020","unstructured":"Al-Amin Shawon M, Abul Khair Yousuf M, Raheem E, et al. Epidemiology, clinical features, and impact of food habits on the risk of hepatocellular carcinoma: a case-control study in Bangladesh. PLoS One. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0232121.","journal-title":"PLoS One"},{"issue":"1","key":"1401_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3126\/mjsbh.v20i1.32256","volume":"20","author":"RK Deo","year":"2021","unstructured":"Deo RK, Chitalkar P, Malla S, Kc I, Karki B, Thapa R. Epidemiology, clinico-radiological profile and management of hepatocellular carcinoma in a tertiary care center in Nepal. Medical Journal of Shree Birendra Hospital. 2021;20(1):6\u201311. https:\/\/doi.org\/10.3126\/mjsbh.v20i1.32256.","journal-title":"Medical Journal of Shree Birendra Hospital"},{"key":"1401_CR40","doi-asserted-by":"publisher","unstructured":"Gnawali A, Pathak R, Koirala D et al. Clinical Profile, risk Factors, and treatment of hepatocellular carcinoma in nepal: A single centre Experience. Published online 2023. https:\/\/doi.org\/10.22541\/au.168797923.34173164\/v1","DOI":"10.22541\/au.168797923.34173164\/v1"},{"key":"1401_CR41","doi-asserted-by":"publisher","unstructured":"Liu Y, Liu L. Changes in the epidemiology of hepatocellular carcinoma in Asia. Cancers (Basel). 2022(18). https:\/\/doi.org\/10.3390\/cancers14184473.","DOI":"10.3390\/cancers14184473"},{"key":"1401_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70004","volume":"45","author":"Q Chen","year":"2025","unstructured":"Chen Q, Huang S, Peng J, Wang P, Shi X, Luo R, et al. The burden of hepatitis B and C in Asia, 1990\u20132019: an update analysis from the Global Burden of Disease Study 2019. Liver Int. 2025;45:e70004. https:\/\/doi.org\/10.1111\/liv.70004.","journal-title":"Liver Int"},{"issue":"9","key":"1401_CR43","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/liv.15251","volume":"42","author":"C Zhang","year":"2022","unstructured":"Zhang C, Cheng Y, Zhang S, Fan J, Gao Q. Changing epidemiology of hepatocellular carcinoma in Asia. Liver Int. 2022;42(9):2029\u201341. https:\/\/doi.org\/10.1111\/liv.15251.","journal-title":"Liver Int"},{"key":"1401_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01081-4","volume":"12","author":"X Du","year":"2023","unstructured":"Du X, Mi J, Cheng H, et al. Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021. Infect Dis Poverty. 2023;12:28. https:\/\/doi.org\/10.1186\/s40249-023-01081-4.","journal-title":"Infect Dis Poverty"},{"issue":"22","key":"1401_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1114560","volume":"11","author":"A Azzeri","year":"2023","unstructured":"Azzeri A, Dahlui M, Mohamed R, McDonald SA, Jaafar H, Shabaruddin FH. Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options. Front Public Health. 2023;11(22):1114560. https:\/\/doi.org\/10.3389\/fpubh.2023.1114560.","journal-title":"Front Public Health"},{"key":"1401_CR46","doi-asserted-by":"publisher","DOI":"10.1159\/000534513","author":"YK Sim","year":"2023","unstructured":"Sim YK, Chong MC, Gandhi M, et al. Real-world data on the diagnosis, treatment, and management of hepatocellular carcinoma in the Asia-Pacific: the INSIGHT study. Liver Cancer. 2023. https:\/\/doi.org\/10.1159\/000534513.","journal-title":"Liver Cancer"},{"issue":"7443","key":"1401_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/bmj.328.7443.823","volume":"328","author":"FF Fikree","year":"2004","unstructured":"Fikree FF, Pasha O. Role of gender in health disparity: the South Asian context. BMJ. 2004;328(7443):823\u20136. https:\/\/doi.org\/10.1136\/bmj.328.7443.823.","journal-title":"BMJ"},{"issue":"7","key":"1401_CR48","doi-asserted-by":"publisher","first-page":"e0158332","DOI":"10.1371\/journal.pone.0158332","volume":"11","author":"N Saikia","year":"2016","unstructured":"Saikia N, Moradhvaj, Bora JK. Gender difference in Health-Care expenditure: evidence from India human development survey. PLoS ONE. 2016;11(7):e0158332. https:\/\/doi.org\/10.1371\/journal.pone.0158332.","journal-title":"PLoS ONE"},{"key":"1401_CR49","doi-asserted-by":"publisher","unstructured":"Singh H, Singh RA. Gender and inequality in access to healthcare facilities in india: evidence from nsso\u2019s 75th round on health. Millennial Asia. 2023;0(0). https:\/\/doi.org\/10.1177\/09763996231195663.","DOI":"10.1177\/09763996231195663"},{"issue":"2","key":"1401_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1535370219898141","volume":"245","author":"D Dhar","year":"2020","unstructured":"Dhar D, Baglieri J, Kisseleva T, Brenner DA. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med. 2020;245(2):96\u2013108. https:\/\/doi.org\/10.1177\/1535370219898141.","journal-title":"Exp Biol Med"},{"issue":"1","key":"1401_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jcar.JCar_9_16","volume":"16","author":"YA Ghouri","year":"2017","unstructured":"Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16(1):1\u20138. https:\/\/doi.org\/10.4103\/jcar.JCar_9_16.","journal-title":"J Carcinog"},{"issue":"2","key":"1401_CR52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/MCG.0b013e3182a030c4","volume":"48","author":"R Jinjuvadia","year":"2014","unstructured":"Jinjuvadia R, Patel S, Liangpunsakul S. The association between metabolic syndrome and hepatocellular carcinoma. J Clin Gastroenterol. 2014;48(2):172\u20137. https:\/\/doi.org\/10.1097\/MCG.0b013e3182a030c4.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"1401_CR53","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922\u201365. https:\/\/doi.org\/10.1097\/HEP.0000000000000466.","journal-title":"Hepatology"},{"issue":"3","key":"1401_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101567","volume":"8","author":"M Ducreux","year":"2023","unstructured":"Ducreux M, Abou-Alfa GK, Bekaii-Saab T, et al. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO\/World Congress on Gastrointestinal Cancer, Barcelona, 2022. ESMO Open. 2023;8(3):101567. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101567.","journal-title":"ESMO Open"},{"issue":"3","key":"1401_CR55","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.018.","journal-title":"J Hepatol"},{"key":"1401_CR56","doi-asserted-by":"publisher","unstructured":"Bhattacharya D, Aronsohn A, Price J, et al. Hepatitis C guidance 2023 update: American association for the study of liver diseases\u2013 infectious diseases society of America recommendations for Testing, Managing, and treating hepatitis C virus Infection. Clinical infectious diseases. Published Online May. 2023;25. https:\/\/doi.org\/10.1093\/cid\/ciad319.","DOI":"10.1093\/cid\/ciad319"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01401-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01401-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01401-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:33:10Z","timestamp":1771061590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01401-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1401"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01401-5","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required for this systematic review, as we used secondary data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}